Objective: The use of local corticosteroid injections for the treatmen
t of Achilles tendonitis is controversial. Some authors advocate their
use based on efficacy in accelerating the healing process of Achilles
tendonitis; others feel the associated side effects should preclude t
heir use altogether. The purpose of this study was to comprehensively
review and critically appraise the available literature in order to ex
amine the evidence concerning this clinical dilemma. Data sources: MED
LINE was searched using MeSH and textwords for English- and French-lan
guage articles related to Achilles tendonitis and corticosteroids publ
ished since 1966. Additional references were reviewed from the bibliog
raphies of the retrieved articles. The total number of articles review
ed was 145. Study selection: All clinical study designs were included
as well as related animal studies using experimental and quasi-experim
ental designs. Data extraction and synthesis: In reviewing the literat
ure, particular attention was paid to the relative strengths of the di
fferent study designs. From these data, the factors associated with ef
fectiveness and safety of injected corticosteroids were examined. Main
results: The only rigorous studies (one randomized controlled trial,
one cohort study) showed no benefit of corticosteroids over placebo. I
n animal studies, corticosteroid injections decrease adhesion formatio
n, temporarily weaken the tendon if given intratendinously, but have n
o effect on tendon strength if injected into the paratenon. The overal
l incidence of side effects with locally injected corticosteroids is s
imilar to 1%. Most side effects are temporary, but skin atrophy and de
pigmentation can be permanent. Although there are many case reports of
Achilles tendon rupture following local corticosteroid injection, the
re are no published rigorous studies that evaluate the risk of rupture
with or without corticosteroid injection. Conclusions: There are insu
fficient published data to determine the comparative risks and benefit
s of corticosteroid injections in Achilles tendonitis. The decreased t
endon strength with intratendinous injections in animal studies sugges
ts that rupture may be a potential complication for several weeks foll
owing injection.